Alan Wilson

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 1.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial

Brian Zambrowicz, J Freiman, Phil Brown et al. · Clinical Pharmacology & Therapeutics · 2012 · 239 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Influence of Molecular Flexibility and Polar Surface Area Metrics on Oral Bioavailability in the Rat

Jing Lü, Kimberly Crimin, Jay T. Goodwin et al. · Journal of Medicinal Chemistry · 2004 · 167 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Optimization of Cryopreservation Procedures for Rat and Human Hepatocytes

Linda J. Loretz, Albert P. Li, M. Wayne Flye et al. · Xenobiotica · 1989 · 165 citations

Life Sciences, Biochemistry, Pharmacology +13

Discovery and Characterization of Novel Tryptophan Hydroxylase Inhibitors That Selectively Inhibit Serotonin Synthesis in the Gastrointestinal Tract

Qingyun Liu, Qi Yang, Weimei Sun et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 154 citations

Medicine, Neuroscience, Pharmacology +17